Clinical Trial Update: HRQoL and Financial Toxicity in Patients With VEXAS Syndrome

View source ↗

Summary

This clinical trial update describes a study evaluating health-related quality of life and financial toxicity in patients with VEXAS syndrome (NCT06657846), whi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vexas Syndrome

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: VEXAS | Status: RECRUITING